Email:
info@genesbio.com
HANGZHOU GENESEA BIOTECHNOLOGY CO., LTD.
News classification
Detection classification
News Detail

The company launched a circulating tumor cell CTC quantity detection service

Issuing time:2018-08-23 11:12

Circulating tumor cells (CTC) refer to tumor cells that enter the human peripheral blood. Malignant tumors are transferred to other organs of the body through the blood, which is the main cause of death of tumor patients. CTC is the seed cells of metastatic tumors. The number of CTCs can help doctors determine the degree of tumor malignancy, drug efficacy, tumor recurrence, patient prognosis, etc., and it has high clinical application value.


Applicable people of early check Kang:

1. Cancer patients before surgery;

Used to help determine whether the tumor is benign or malignant and whether it has metastasized.

2. Patients undergoing drug treatment after surgery;

It is used to judge whether the therapeutic drug is effective, and the therapeutic effect of the drug can be judged within 1-2 weeks after taking the drug.

3. Surgery and medication to treat patients with effective tumors;

It can be tested regularly to determine whether the tumor has recurred or metastasized.



  • 图片5.png

    CTC detection diagram

    图片7.png

    CTC immunofluorescence photo


Professional quality Trust brand
We are a high-tech enterprise specializing in the development and production of pharmaceuticals, biological products and testing reagents.
HANGZHOU GENESEA BIOTECHNOLOGY CO., LTD.
A high-tech enterprise specializing in the development and production of pharmaceuticals, biological products and testing reagents.
Address: 3rd Floor, Builiding 5, No. 1 Xiyuan Road, Xihu District, hangzhou, China
Email:info@genesbio.com
——————————————————————————————————————————————————————————————————————————————